Trial Profile
Study of Elbasvir/Grazoprevir (EBR/GZR) in Genotype 1 (GT1) Infected Patients with and without Liver Cirrhosis in German Real-World
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2021
Price :
$35
*
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms DHC-R
- 13 Dec 2018 New trial record
- 13 Nov 2018 Results presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases